General Informations
Aperçu des sections
Biotechnology of innovative therapies for the academic year 2025/2026
Biotechnology is the engine behind a medical revolution, turning fundamental biological discoveries into innovative therapies capable of treating—or even curing—complex diseases like cancer or rare genetic disorders.
🧬 Key Types of Innovative Therapies
Current advances focus on using biological systems to create highly targeted treatments:
- Gene Therapy: Modifying a patient’s genetic material to treat a disease at its source.
- CRISPR-Cas9: A genomic editing tool that "cuts" and "repairs" DNA with precision, currently used for conditions like sickle cell anemia.
- Viral Vectors: Using modified viruses (like AAV or lentiviruses) to deliver healthy genes into target cells.
- Cell Therapy (CAR-T): A patient’s immune cells (T cells) are harvested, genetically reprogrammed in a lab to recognize cancer cells, and then re-infused to destroy the tumor.
- Therapeutic Proteins: Producing complex molecules like monoclonal antibodies, recombinant insulin, or growth hormones using genetically modified cells.
- mRNA Vaccines : Technology that instructs the body's cells to produce a protein that triggers an immune response, popularized by COVID-19 vaccines but now being tested for cancer.
🚀 Challenges & Future Perspectives
- Artificial Intelligence : AI is now accelerating the discovery of new therapeutic targets and optimizing manufacturing processes (biomanufacturing).
- Industrial Bioproduction: A major challenge remains scaling up from lab research to safe, large-scale production (GMP standards) to make these treatments affordable.
- Regulation: Development is strictly monitored by agencies like the EMA (Europe) or FDA (USA) to ensure patient safety throughout the clinical trial phases.
